(Q33447721)

26 July 2017

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). (English)

1 reference

26 July 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

Larisa Rudenko

1

0 references

Svetlana Donina

7

object named as

Svetlana Donina

1 reference

26 July 2017

Julia Desheva

2

1 reference

26 July 2017

Sergey Korovkin

3

1 reference

26 July 2017

Alexander Mironov

4

1 reference

26 July 2017

Andrey Rekstin

5

1 reference

26 July 2017

Elena Grigorieva

6

1 reference

26 July 2017

Alexandra Gambaryan

8

1 reference

26 July 2017

Anton Katlinsky

9

1 reference

26 July 2017

1 November 2008

1 reference

Influenza and Other Respiratory Viruses

26 July 2017

1 reference

26 July 2017

2

1 reference

26 July 2017

6

1 reference

26 July 2017

203-209

1 reference

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1750-2659.2008.00064.X

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634119

PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19453396

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1750-2659.2008.00064.X

1 reference

26 July 2017

1 reference

26 July 2017

1 reference